ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

436
Analysis
Health Care • South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
•21 Aug 2024 06:00•Broker

China Healthcare - Overseas CXO/ Life Science Upstream 2Q24 Review

We have summarized 2Q24 earnings of major overseas CXO and life science upstream (LSU) companies, which engage in clinical CROs, preclinical CROs,...

Logo
270 Views
Share
bullish•Quantitative Analysis
•21 Aug 2024 06:00

KRX Short Interest Weekly (Aug 16th): Sk Hynix

We analyzed KRX short interest report for the past week and highlighted short interest changes in Sk Hynix (ticker: 000660 KS).

Logo
325 Views
Share
bullish•Quantitative Analysis
•19 Aug 2024 07:05

KRX Foreign Holding Weekly (Aug 16th): Samsung Electronics, Sk Hynix, Naver

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Sk Hynix, Naver.

Logo
306 Views
Share
bullish•Quantitative Analysis
•14 Aug 2024 06:00

KRX Short Interest Weekly (Aug 9th): Celltrion, Sk Hynix, Samsung Heavy Industries, L&F, Posco

We analyzed KRX short interest report for the past week and highlighted short interest changes in Celltrion, Sk Hynix, Samsung Heavy Industries,...

Logo
323 Views
Share
bullish•Quantitative Analysis
•12 Aug 2024 07:05

KRX Foreign Holding Weekly (Aug 9th): Samsung Electronics, Sk Hynix

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Sk Hynix.

Logo
286 Views
Share
x